Please login to the form below

Not currently logged in
Email:
Password:

DARPin

This page shows the latest DARPin news and features for those working in and with pharma, biotech and healthcare.

Allergan will start phase III DARPin trials next year

Allergan will start phase III DARPin trials next year

Will investigate drug in wet age-related macular degeneration. Allergan confirmed yesterday it will start pivotal trials of its DARPin treatment for wet age-related macular degeneration (AMD) in the first ... The company reckons that DARPin could expand

Latest news

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Collaboration, licence. 830. Molecular Partners/ Allergan. Option exercise for 2 DARPins from Allergan's ophthalmology alliance signed in 2012.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics